Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
Jianping Liu,1 Weihua Zhao,2 Qinghong Gui,1 Ying Zhang,1 Zaiyu Guo,2 Wei Liu3 1Department of Neurology, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 2Department of Neurosurgery, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 3Department o...
Enregistré dans:
Auteurs principaux: | Liu J, Zhao W, Gui Q, Zhang Y, Guo Z, Liu W |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/569af6e1e66f48bba1c0427cc4f4b6be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease
par: Nanae Ishida, et autres
Publié: (2021) -
Total Cerebral Small Vessel Disease Burden on MRI Correlates With Cognitive Impairment in Outpatients With Amnestic Disorders
par: Yangyi Fan, et autres
Publié: (2021) -
Clinicoradiographic and genetic features of cerebral small vessel disease indicate variability in mode of inheritance for monoallelic HTRA1 variants
par: Karthik Muthusamy, et autres
Publié: (2021) -
Endothelial Dysfunction and Hyperhomocysteinemia-Linked Cerebral Small Vessel Disease: Underlying Mechanisms and Treatment Timing
par: Shuang Li, et autres
Publié: (2021) -
Pre-operative Cerebral Small Vessel Disease on MR Imaging Is Associated With Cerebral Hyperperfusion After Carotid Endarterectomy
par: Xiaoyuan Fan, et autres
Publié: (2021)